Trial intelligence / Profile preview

Mosapride vs domperidone for gastroparesis in Parkinson's disease (randomized double blind double dummy)

TCTR20220821001Phase 3Unknown

Sponsor
Faculty of Medicine, Prince of Songkhla University
Start
Aug 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Parkinson's disease (PD) and gastroparesis comparing Mosapride arm with Domperidone arm (2 arms). Status: unknown.

02

Drugs

mosapridedomperidone
03

Conditions

Parkinson's disease (PD)gastroparesis

Beyond the preview

Go deeper on TCTR20220821001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20220821001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call